Cancer is a disease characterized by the uncontrolled growth of cells and is the leading
cause of death worldwide with an incidence of 11 million new cases each year …

Background: Nanocarriers have been a part of drug delivery for some decades now. Due to
the enormous advantages offered by them, they are replacing the conventionally available …

Background: Cancer was and still a very stressful and urgent disease condition representing
a leading cause of death in developed as well as developing countries. Although, much …

Cancer is a leading cause of death worldwide. Conventional chemotherapy has drawbacks
ranging from limited effectiveness, chemoresistance, and treatment-related side-effects and …

Anticancer therapies mostly depend on the ability of the bioactives to reach their designated
cellular and subcellular target sites, while minimizing accumulation and side effects at non …

Nanotechnology has been actively integrated as drug carriers over the last few years to treat
various cancers. The main hurdle in the clinical management of cancer is the development …

The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can
improve the pharmacological properties of commonly used compounds in cancer diagnosis …

Nanotechnology has recently gained increased attention for its capability to effectively
diagnose and treat various tumors. Nanocarriers have been used to circumvent the …

CONCLUSION Nanomedicine is proving to be a rather attractive modality in the
management of several diseases including cancer. However, it is of paramount importance …

In recent years, due to the shortcomings of conventional chemotherapy, such as poor
bioavailability, low treatment index, and unclear side effects, the focus of cancer research …